Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

Autor: Meulenbeld, H.J., van Werkhoven, E.D., Coenen, J.L.L.M., Creemers, G.J., Loosveld, O.J.L., de Jong, P.C., ten Tije, A.J., Fosså, S.D., Polee, M., Gerritsen, W., Dalesio, O., de Wit, R.

Publikováno v: In European Journal of Cancer November 2012 48(16):2993-3000

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Survival benefit of resection of locally advanced pancreatic cancer following upfront FOLFIRINOX versus FOLFIRINOX only treatment: A propensity score-matched analysis

Autor: Brada, L., Daamen, L., Magermans, L., Walma, M., Latifi, D., van Dam, R., de Hingh, I., Liem, M., de Meijer, V., Patijn, G., Festen, S., Stommel, M., Bosscha, K., Polee, M., Nio, Y., Wessels, F., de Vries, J., van Lienden, K., Bruijnen, R., Busch, O., Koerkamp, B. Groot, van Eijck, C., Molenaar, Q., Wilmink, H., van Santvoort, H., Besselink, M.

Publikováno v: In Pancreatology July 2021 21 Supplement 1:S84-S84

Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers.

Autor: Verhaart SL; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, United Kingdom., Abu-Ghanem Y; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Mulder SF; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Oosting S; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Van Der Veldt A; Department of Medical Oncology, Erasmus Medical Center-Cancer Institute, Rotterdam, The Netherlands., Osanto S; Department of Medical Oncology, Leids University Medical Center, Leiden, The Netherlands., Aarts MJB; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands., Houtsma D; Department of Medical Oncology, HAGA Hospital, The Hague, The Netherlands., Peters FPJ; Department of Medical Oncology, Zuyderland Hospital, Sittard - Geleen, The Netherlands., Groenewegen G; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Pronk LM; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Tascilar M; Department of Medical Oncology, Isala Clinics, Zwolle, The Netherlands., Hamberg P; Department of Medical Oncology, Franciscus Gasthuis and Vllietland, Rotterdam, The Netherlands., Los M; Department of Medical Oncology, St. Antonius Hospital, Nieuwegein, The Netherlands., Vreugdenhil G; Department of Medical Oncology, Máxima Medical Center, Eindhoven, The Netherlands., Polee M; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Ten Tije AJ; Department of Medical Oncology, Amphia Hospital, Breda, The Netherlands., Haanen JBAG; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bex A; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; Division of Surgery and Interventional Science, University College London, London, United Kingdom; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: axel.bex@nhs.net., van den Eertwegh AJ; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, United Kingdom.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2021 Jun; Vol. 19 (3), pp. 274.e1-274.e16. Date of Electronic Publication: 2020 Oct 14.

Development and internal validation of two nomograms predicting outcomes in patients with locally advanced pancreatic cancer starting treatment with FOLFIRINOX

Autor: Brada, L., Walma, M., Daamen, L., Van Roessel, S., Van Dam, R., De Hingh, I., Liem, M., De Meijer, V., Patijn, G., Festen, S., Stommel, M., Meijerink, M., Bosscha, K., Polée, M., Ropela, A., Nio, Y., Wessels, F., Van Leeuwen, M., De Vries, J., Van Lienden, K., Bruijnen, R., Busch, O., Besselink, M., Molenaar, Q., Van Santvoort, H.

Publikováno v: In Pancreatology November 2020 20 Supplement 1:S44-S45